SQSTM1 and tauopathy: Our findings collectively implicate β-arrestin1 in several events that promote tauopathy: transducing the agonist-occupied GPCR signal to tau phosphorylation, destabilization of microtubules which releases tau and promotes tau mislocalization, and inhibition of p62-mediated tau clearance (Fig 7A and B).